XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and Intangible Assets, Net (Tables)
 9 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)
U.S. Pharmaceutical (1)
Prescription Technology SolutionsMedical-Surgical Solutions
International
Total
Balance, March 31, 2023$4,050 $2,005 $2,453 $1,439 $9,947 
Goodwill acquired— — — 3 3 
Foreign currency translation adjustments, net— — — 30 30 
Other adjustments (2)
(7)— — — (7)
Balance, December 31, 2023$4,043 $2,005 $2,453 $1,472 $9,973 
(1)The goodwill balance allocated to the U.S. Pharmaceutical segment related to McKesson Europe’s Celesio AG acquisition no longer reflects foreign currency translation adjustments as its functional currency was changed from Euros to U.S. dollars with the completion of the sale of the E.U. disposal group.
(2)Includes purchase price allocation adjustments related to the formation of SCRI Oncology, which is discussed in Financial Note 2, “Business Acquisitions and Divestitures.”
Schedule of information regarding intangible assets
Information regarding intangible assets was as follows:
 December 31, 2023March 31, 2023
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Customer relationships11$1,800 $(676)$1,124 $2,971 $(1,765)$1,206 
Service agreements101,131 (663)468 1,137 (623)514 
Trademarks and trade names12760 (388)372 833 (430)403 
Technology10244 (120)124 264 (129)135 
Other633 (24)9 193 (174)19 
Total (1)
 $3,968 $(1,871)$2,097 $5,398 $(3,121)$2,277 
(1)During the third quarter of fiscal 2024, the Company performed a review of its intangible assets and removed from the balance sheet $1.4 billion of fully amortized gross intangible assets and the corresponding accumulated amortization associated with the assets that no longer provide an economic benefit, are no longer in use, or for which the related contract has expired.